Navigation Links
Heidelberg Retina Angiograph 2 (HRA 2)

ProductsHeidelberg Retina Angiograph 2 (HRA 2)
Company Heidelberg Engineering, Inc.
Item Heidelberg Retina Angiograph 2 (HRA 2)
Features 
  • Highest Image Contrast and Detail
  • Lowest Light Exposure
  • Fluorescein Angiography (FA)
  • ICG Angiography (ICGA)
  • Simultaneous FA and ICGA
  • Infra-red and Blue Reflectance
  • Autofluorescence
  • Stereo and Widefield Imaging
  • 3D scanning
  • Compact
Description The HRA 2 enables you to perform standard high-resolution and high-contrast fluorescein and ICG angiography as well as autofluorescence (488 nm) imaging with high quality.

Using the normal FA settings, but without the injection of fluorescein, autofluorescence imaging can increase physician confidence by confirming the diagnosis in such conditions as macular holes, pseudo-vittelliform lesions, RPE Atrophy, Central Serous Chorioretinopathy and Bests disease.

A unique feature of the HRA 2 is the ability to acquire dynamic, highspeed movies (up to 16 frames per second) in both Fluorescein or ICG Angiographies. This is especially important in the initial phase of FAs, when documentation of the early filling stages is necessary. In ICGA, this feature enables better detection of CNV characteristics such as feeder vessels and RCA/RAPs. Its great for teaching.

Never before have you been able to see dynamic angiography sequences and the movie feature allows a retrospective review of your angiographies.

Every time you review a movie its like being there at the time of the procedure. While going over the acquired image series you can extract single images from the sequence which can be viewed and printed if necessary.

Info Heidelberg Engineering, Inc.
Customer Service: (800) 931-2230
Web site: http://www.heidelbergengineering.com

Related medicine products :

1. Heidelberg Retina Tomograph
2. Heidelberg Retina Tomograph II
3. Heidelberg Retina Flowmeter (HRF)
4. Heidelberg Multi Color (HMC) Anomaloscope
5. Heidelberg Retina Tomograph 3 (HRT3)
6. Gass Retinal Detachment Hook
7. Olk Angled Retinal Pick - 110 Degree
8. Olk Angled Retinal Pick - 150 Degree
9. Olk Angled Retinal Pick - 130 Degree
10. Weiss Retinal Pick 90 Degree Long
11. Weiss Retinal Pick 120 Degree Long
Poly stat Strep A is a lateral flow, one-step immunoassay for the rapid, qualitative detection of Group A Streptococcal antigen from throat swabs. The test is intended for use as an aid in the diagn
...he ProTime Microcoagulation System monitors warfar...ient self-testing. Enhancements include an easy-t...le and replaceable battery. Software updates incl... computer or be transmitted to a LIS or EMR databa...
...ince 1994 the CoaguChek System has been providing ...eeded most, at the point of care. , The CoaguChe... of patients self-testing when monitoring on Couma...m allows the user to obtain a result from a finger...
...he Instacup Multi-Drug Screen Panel is used for th...man urine. The Instacup Panel consists of a test c... test card is inserted and the sample sealed with ...ot necessary to remove the test card to read the r...
Medicine Products:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...he spread of the disease are clearly not working a...// on a global basis if the disease is to be conta...ups of sex workers and drug addicts. It is here t...ortance. Individuals the world over, both in devel...
...ted by Welcare World Health Systems, has been lau...bulatory health care service comprising of outpati.../ services had been recently inagurated in Knowle... Ambulatory Care Center is open from 8 am to 11 pm...
...cross the world, according to the Center for Socia...bin Room. About 4.4% of deaths are accounted for b.... Alcohol is also responsible for as many deaths a...aws have reportedly failed to take note of this fa...
...al and Experimental Research which has revealed th... result in lesser consumption//. It only contribut...ior liquor. Researchers believe across-the-board ...e intended effects on alcohol sales, and suggest '...
Other Medicine News:Health News:Need of the Hour: Viable Strategies against AIDS 2Health News:State Of The Art Healthcare Facility Opened In 'New Dubai' by Welcare 2Health News:Price Of Alcohol Does Not Influence Consumption 2
(Date:10/6/2008)... More than 60 percent of moderate to severe pati... percent achieved endoscopic remission at Week 10,...at the American College,of Gastroenterology (ACG) .../- UCB today presented data from a,la...provement in Crohn,s,disease (CD) with a biologic ...
(Date:10/6/2008)... Improved Pharmacokinetic Characteristics of Naltr...erability in Clinical Trials -, PHOENIX, Oct. 6 /...c.,(Nasdaq: OREX ), a biopharmaceutical company f...al nervous system-related disorders, today present...(R) (naltrexone SR /,bupropion SR), successfully a...
(Date:10/6/2008)... SEATTLE, Oct. 6 /- Dendr...nce call today, Monday, October 6, 2008 at 9:00 AM...rim analysis of its IMPACT,(IMmunotherapy for Pros...B),clinical trial of PROVENGE(R) (sipuleucel-T), t...otherapy for the treatment of advanced prostate,ca...
(Date:10/6/2008)... Recent study revealed that drinking polyphenol-...ith changes in appetite, energy intake or body,wei...ar consumption of 100%,polyphenol-rich Concord gra...s not associated with changes in appetite and was ...ew data presented at the 49th Annual Meeting of,th...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3New Source of Heart Stem Cells Found 22491 1New Source of Heart Stem Cells Found 22491 2RxPop com Wins 7th Annual Horizon Interactive Award 22487 1RxPop com Wins 7th Annual Horizon Interactive Award 22487 2Health and Beauty Come Full Circle 3A Chado En Brings Full Benefit of Japanese Green Tea to Spas 22483 1Health and Beauty Come Full Circle 3A Chado En Brings Full Benefit of Japanese Green Tea to Spas 22483 2Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 1Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 2Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 3Concuity Announces Partnership with Financial Healthcare Systems LLC 6148 4
...rQule, Inc.,(NASDAQ: ARQL) today announced that th... accepted for oral presentation the,Company,s abst...of,ARQ 197, a Selective Inhibitor of the c-Met Rec... the 43rd ASCO Annual Meeting, June,1-5, 2007, in ...from a Phase 1 trial with ARQ 197, a selective, sm...
...II Trial Results,For Novel Oral Thrombin Receptor ...can College Of Cardiology/i2 Summit, KENILWORTH, N...ring-Plough Corporation announced today that resul...n receptor antagonist (TRA),SCH 530348 will be pre...he of Cardiology (ACC.07)/Innovation in Interventi...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2